Grifols announced the postponement until further notice of its previously scheduled Capital Markets Day for October 10, 2024. “The Grifols Board of Directors made the decision in light of the potential delisting offer for Grifols’ shares being evaluated by Brookfield Capital Partners and certain major shareholders of Grifols linked to the company’s founding family. Currently, the Potential Offerors are in process of performing due diligence. At this time, there is no offer, agreement, or decision regarding the potential transaction or its related terms and conditions, nor is there any guarantee or commitment that an offer for Grifols’ shares will be made. The Grifols Board and management team are committed to acting in the best interest of all shareholders and remain focused on continuing to execute and deliver Grifols’ strategy. Any further update will be communicated to the market in due course and in accordance with applicable laws and regulations,” the company stated.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Brookfield in talks to join buyout of Grifols, Bloomberg reports
- Brookfield in talks to join sovereign funds in Grifols bid, Bloomberg says
- Grifols receive FDA clearance of IND application for Phase 1 trial of GIGA-2339
- Grifols restates financials for first half of 2024 due to incorrect accounting
- Grifols price target raised to EUR 15.45 from EUR 14.85 at Berenberg